Skip to content

A prospective, controlled, clinical study to evaluate the impact of UV-irradiation on the electrical impedance spectroscopy scores of nevi

A prospective, controlled, clinical study to evaluate the impact of UV-irradiation on the electrical impedance spectroscopy scores of nevi

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00012456
Enrollment
50
Registered
2017-07-07
Start date
2017-08-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Q82.5

Interventions

Group 1: In this study a intraindividual control will be performed. Two nevi will be measured in the same body area, if possible the nevi should be almost identical. Measurement of electrical impedanc

Sponsors

Universitätsklinikum Heidelberg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients = 18 years of age, Patients scheduled for elective ultraviolet B (NB-UVB) phototherapy, Existence of two common nevi in the same body area

Exclusion criteria

Exclusion criteria: Patients that are unable to give informed consent, Expected lack of compliance

Design outcomes

Secondary

MeasureTime frame
A secondary objective of this study is to assess the repeatability of EIS scores by performing two measurements for each lesion at one time point.

Primary

MeasureTime frame
The primary objective of this study is to assess the influence of NB-UVB phototherapy on the EIS scores of nevi. Two nevi will be measured before and directly after phototherapy and a third time after 4 weeks after stop of phototherapy. One of these nevi will be covered with a opaque tape during the whole phototherapy.

Countries

Germany

Contacts

Public ContactHolger Haenssle

Universitäts-Hautklinik Heidelberg

holger.haenssle@med.uni-heidelberg.de00496221568511

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 25, 2026